Cargando…
Immunosuppressive Property of MSCs Mediated by Cell Surface Receptors
In the past decade, mesenchymal stem cells (MSCs) tend to exhibit inherent tropism for refractory inflammatory diseases and engineered MSCs have appeared on the market as therapeutic agents. Recently, engineered MSCs target to cell surface molecules on immune cells has been a new strategy to improve...
Autores principales: | Liu, Siyu, Liu, Fei, Zhou, You, Jin, Baeku, Sun, Qiang, Guo, Shu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399134/ https://www.ncbi.nlm.nih.gov/pubmed/32849489 http://dx.doi.org/10.3389/fimmu.2020.01076 |
Ejemplares similares
-
TA-MSCs, TA-MSCs-EVs, MIF: their crosstalk in immunosuppressive tumor microenvironment
por: Zhang, Zhenghou, et al.
Publicado: (2022) -
Immunomodulatory Effect of MSCs and MSCs-Derived Extracellular Vesicles in Systemic Lupus Erythematosus
por: Yang, Chunjuan, et al.
Publicado: (2021) -
Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs
por: Weiss, Andreas Robert Rudolf, et al.
Publicado: (2019) -
Editorial: Immunomodulation of MSCs in tissue repairing and regeneration
por: Peng, Yanwen, et al.
Publicado: (2023) -
Glycolytic reprogramming in macrophages and MSCs during inflammation
por: Li, Xueping, et al.
Publicado: (2023)